Merrill Lynch Warns of Post-Election Double Whammy
Merrill Lynch Wealth Management recommends three talking points for financial advisors to keep in mind when talking with their clients.
SEC, FINRA, DOL Enforcement Roundup: 8 Charged for Insider Trading on Pharma Deal
Among the recent actions taken by the regulators were a settlement of $1.27 million to be paid by an advisory firm to 13 pension plans and charges in an insider trading ring.
SEC, FINRA Enforcement Roundup: Bristol-Myers Squibb Exec Charged
There was an international flavor to some of the recent actions taken by the SEC and FINRA, including freezing $38 million in assets in an international insider trading case and charges involving a Chinese reverse merger company.
How Long Can Advisors Avoid Public Disclosure of Their Conflicts of Interest?
A ProPublica investigation has revealed the scope of payments to doctors by pharmaceutical companies. Will advisors be next in line for public scrutiny of their finances?
Fiduciary Debate: What if Doctors Could Act Like Advisors?
Wherein our intrepid blogger applies the logician's reductio ad absurdum argument to the current debate over applying the fiduciary standard to brokers, or not.
Emerging Markets Middle Class Is on the Rise, Ready to Spend
The worldwide economic picture may be full of uncertainties but one thing seems likely: the demand for goods and services in the developing world will grow at an unprecedented rate.
Charitable Giving in U.S. Edged Up to $291B in 2010
Total charitable contributions from American individuals, corporations and foundations grew by 3.8% in 2010 in current dollars and 2.1% in inflation-adjusted dollars, according to estimates released Monday by Giving USA Foundation and its research partner, the Center on Philanthropy at Indiana University.
After the traumatic events of the last few years, some of your clients may be experiencing a crisis of confidence in our economic system, institutions and leaders.
Biotech/Health Care: Growth Drivers
John T. Boris Citigroup Global Markets firstname.lastname@example.org 212-816-1635 The U.S. major pharmaceutical group is trading at 8.3x (times) 2011 estimated earnings per share (EPS), representing a 32 percent discount...
Have you noticed that as the baby boom generation ages, the advertising we see on television changes along with them? Think back to those golden...